Furthermore, we examined tau isoforms in the Sarkosyl soluble and insoluble fractions, which is a standard protocol used to extract pathological tau from human AD brain tissue,38, 45 and immunofluorescent staining and immunohistochemistry to visualize the 3R and 4R tau in brain tissue (Figure 1D). This evidence concerns the gene MAPT and Alzheimer disease.